Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 10
Submit an article Journal homepage
246
Views
3
CrossRef citations to date
0
Altmetric
Letter

Long-term results of the R-CEOP90 in the treatment of young patients with chemotherapy-naïve diffuse large B cell lymphoma: A phase II study

Qi-Chun CaiDepartment of Medical Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaCorrespondence[email protected]
,
Yan GaoLymphoma Center, Department of Medical Oncology, Guangzhou, ChinaCorrespondence[email protected]
,
Xiao-Xiao WangLymphoma Center, Department of Medical Oncology, Guangzhou, China
,
Qing-Qing CaiLymphoma Center, Department of Medical Oncology, Guangzhou, China
,
Ze-Xiao LinDepartment of Medical Oncology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
,
Bing BaiLymphoma Center, Department of Medical Oncology, Guangzhou, China
,
Ying GuoDepartment of GCP, Cancer Center of Sun Yat-sen University, State Key Laboratory of Oncology in Southern China, Guangzhou, China
&
Hui-Qiang HuangLymphoma Center, Department of Medical Oncology, Guangzhou, ChinaCorrespondence[email protected]
 show all
Pages 2387-2388 | Received 12 Jun 2013, Accepted 10 Dec 2013, Published online: 17 Feb 2014

References

  • Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d’Etudes des Lymphomes de l’Adulte. Blood 2010;116:2040–2045.
  • Torti FM, Bristow MM, Lum BL, et al. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res 1986;46:3722–3727.
  • Huang HQ, Lin XB, Pan ZH, et al. CEOP regimen in the treatment for non-Hodgkin's lymphoma. Chin J Oncol 2007;29:391–395.
  • Watanabe T, Tobinai K, Shibata T, et al. Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 Trial. J Clin Oncol 2011;29:3990–3998.
  • Gang AO, Strøm C, Pedersen M, et al. R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Ann Oncol 2012;23:147–153.
  • Basaran M, Bavbek ES, Sakar B, et al. Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study. Am J Clin Oncol 2001;24:570–575.
  • Terada Y, Nakamae H, Aimoto R, et al. Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma. J Exp Clin Cancer Res 2009;28:116.
  • Pfreundschuh M, Kuhnt E, Trümper L, et al. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 2011;12:1013–1022.
  • Vitolo U, Liberati AM, Cabras MG, et al. High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an “Intergruppo Italiano Linfomi” randomized trial. Haematologica 2005;90:793–801.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.